Los Angeles Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,501
| Closed | -$57K | – | 1207 |
|
|
2024
Q4 | $57K | Hold |
10,501
| – | – | ﹤0.01% | 1095 |
|
|
2024
Q3 | $75.8K | Hold |
10,501
| – | – | ﹤0.01% | 1147 |
|
|
2024
Q2 | $114K | Sell |
10,501
-4,847
| -32% | -$52.6K | ﹤0.01% | 1152 |
|
|
2024
Q1 | $288K | Hold |
15,348
| – | – | ﹤0.01% | 1020 |
|
|
2023
Q4 | $333K | Buy |
+15,348
| New | +$333K | ﹤0.01% | 986 |
|
|
2022
Q2 | – | Sell |
-13,030
| Closed | -$431K | – | 1443 |
|
|
2022
Q1 | $431K | Buy |
+13,030
| New | +$431K | ﹤0.01% | 1098 |
|
|
2019
Q2 | – | Sell |
-8,321
| Closed | -$1.32M | – | 1414 |
|
|
2019
Q1 | $1.32M | Buy |
+8,321
| New | +$1.32M | 0.01% | 767 |
|
|
2018
Q4 | – | Sell |
-1,570
| Closed | -$222K | – | 1367 |
|
|
2018
Q3 | $222K | Sell |
1,570
-87,686
| -98% | -$12.4M | ﹤0.01% | 1309 |
|
|
2018
Q2 | $14M | Buy |
89,256
+58,069
| +186% | +$9.09M | 0.08% | 289 |
|
|
2018
Q1 | $5.02M | Buy |
31,187
+28,087
| +906% | +$4.52M | 0.03% | 429 |
|
|
2017
Q4 | $511K | Sell |
3,100
-350
| -10% | -$57.7K | ﹤0.01% | 1044 |
|
|
2017
Q3 | $215K | Buy |
+3,450
| New | +$215K | ﹤0.01% | 1238 |
|
|
2016
Q3 | – | Sell |
-6,890
| Closed | -$208K | – | 1272 |
|
|
2016
Q2 | $208K | Buy |
+6,890
| New | +$208K | ﹤0.01% | 1151 |
|